Swelling, redness, warmth, weakness, dark urine, fainting, chest pain, shortness of breath, or cramping alongside significant vomiting or diarrhea are signs it's time to call your provider, not wait it out
These response rates far exceed what traditional weight loss interventions typically achieve
Keywords: GLP-1 receptor agonists, psoriasis, wound healing, hidradenitis suppurativa, cutaneous adverse effects Introduction Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced in the intestinal epithelial endocrine L-cells following meal intake
Research has associated GLP-1 medications with a higher risk of bowel obstruction compared to other weight loss drugs